352 related articles for article (PubMed ID: 26382761)
1. Efficacy and Safety of Antifibrinolytic Agents in Reducing Perioperative Blood Loss and Transfusion Requirements in Scoliosis Surgery: A Systematic Review and Meta-Analysis.
Wang M; Zheng XF; Jiang LS
PLoS One; 2015; 10(9):e0137886. PubMed ID: 26382761
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of antifibrinolytic agents on surgical bleeding and transfusion requirements in spine surgery: a meta-analysis.
Li G; Sun TW; Luo G; Zhang C
Eur Spine J; 2017 Jan; 26(1):140-154. PubMed ID: 27671279
[TBL] [Abstract][Full Text] [Related]
3. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children.
Tzortzopoulou A; Cepeda MS; Schumann R; Carr DB
Cochrane Database Syst Rev; 2008 Jul; (3):CD006883. PubMed ID: 18646174
[TBL] [Abstract][Full Text] [Related]
4. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children.
McNicol ED; Tzortzopoulou A; Schumann R; Carr DB; Kalra A
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD006883. PubMed ID: 27643712
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of tranexamic acid in reducing blood loss in scoliosis surgery: a systematic review and meta-analysis.
Yuan QM; Zhao ZH; Xu BS
Eur Spine J; 2017 Jan; 26(1):131-139. PubMed ID: 27900553
[TBL] [Abstract][Full Text] [Related]
6. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
Cochrane Database Syst Rev; 2011 Jan; (1):CD001886. PubMed ID: 21249650
[TBL] [Abstract][Full Text] [Related]
7. Are antifibrinolytics helpful in decreasing blood loss and transfusions during spinal fusion surgery in children with cerebral palsy scoliosis?
Dhawale AA; Shah SA; Sponseller PD; Bastrom T; Neiss G; Yorgova P; Newton PO; Yaszay B; Abel MF; Shufflebarger H; Gabos PG; Dabney KW; Miller F
Spine (Phila Pa 1976); 2012 Apr; 37(9):E549-55. PubMed ID: 22037532
[TBL] [Abstract][Full Text] [Related]
8. The relative efficacy of antifibrinolytics in adolescent idiopathic scoliosis: a prospective randomized trial.
Verma K; Errico T; Diefenbach C; Hoelscher C; Peters A; Dryer J; Huncke T; Boenigk K; Lonner BS
J Bone Joint Surg Am; 2014 May; 96(10):e80. PubMed ID: 24875032
[TBL] [Abstract][Full Text] [Related]
9. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD001886. PubMed ID: 21412876
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of tranexamic acid in reducing allogeneic blood products in adolescent idiopathic scoliosis surgery.
Sui WY; Ye F; Yang JL
BMC Musculoskelet Disord; 2016 Apr; 17():187. PubMed ID: 27117696
[TBL] [Abstract][Full Text] [Related]
11. Role of Amicar in surgery for neuromuscular scoliosis.
Thompson GH; Florentino-Pineda I; Poe-Kochert C; Armstrong DG; Son-Hing J
Spine (Phila Pa 1976); 2008 Nov; 33(24):2623-9. PubMed ID: 18981961
[TBL] [Abstract][Full Text] [Related]
12. A systematic review and meta-analysis of the use of antifibrinolytic agents in total hip arthroplasty.
Huang F; Wu Y; Yin Z; Ma G; Chang J
Hip Int; 2015; 25(6):502-9. PubMed ID: 26620803
[TBL] [Abstract][Full Text] [Related]
13. The role of Amicar in same-day anterior and posterior spinal fusion for idiopathic scoliosis.
Thompson GH; Florentino-Pineda I; Poe-Kochert C; Armstrong DG; Son-Hing JP
Spine (Phila Pa 1976); 2008 Sep; 33(20):2237-42. PubMed ID: 18794767
[TBL] [Abstract][Full Text] [Related]
14. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; McClelland B; Laupacis A; Fergusson D
Cochrane Database Syst Rev; 2007 Oct; (4):CD001886. PubMed ID: 17943760
[TBL] [Abstract][Full Text] [Related]
15. The effect of amicar on perioperative blood loss in idiopathic scoliosis: the results of a prospective, randomized double-blind study.
Florentino-Pineda I; Thompson GH; Poe-Kochert C; Huang RP; Haber LL; Blakemore LC
Spine (Phila Pa 1976); 2004 Feb; 29(3):233-8. PubMed ID: 14752343
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of antifibrinolytic agents in spinal surgery: a network meta-analysis.
Yuan L; Zeng Y; Chen ZQ; Zhang XL; Mai S; Song P; Tao LY
Chin Med J (Engl); 2019 Mar; 132(5):577-588. PubMed ID: 30807356
[TBL] [Abstract][Full Text] [Related]
17. Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials.
Carless PA; Moxey AJ; Stokes BJ; Henry DA
BMC Cardiovasc Disord; 2005 Jul; 5():19. PubMed ID: 15992412
[TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusions for duchenne muscular dystrophy scoliosis.
Shapiro F; Zurakowski D; Sethna NF
Spine (Phila Pa 1976); 2007 Sep; 32(20):2278-83. PubMed ID: 17873823
[TBL] [Abstract][Full Text] [Related]
19. Perioperative blood transfusion requirements in pediatric scoliosis surgery: the efficacy of tranexamic acid.
Grant JA; Howard J; Luntley J; Harder J; Aleissa S; Parsons D
J Pediatr Orthop; 2009; 29(3):300-4. PubMed ID: 19305284
[TBL] [Abstract][Full Text] [Related]
20. Can tranexamic acid conserve blood and save operative time in spinal surgeries? A meta-analysis.
Hui S; Xu D; Ren Z; Chen X; Sheng L; Zhuang Q; Li S
Spine J; 2018 Aug; 18(8):1325-1337. PubMed ID: 29246849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
